EUVIMEDEUVIMED entdecken
Crossref

Early-Phase C-Peptide Response as a Candidate Predictor of Cystic Fibrosis-Related Diabetes in People With Normal Glucose Tolerance: A Multicenter Retrospective Survival Analysis

Andrea Foppiani, Fabiana Ciciriello, Beatrice Marelli, Federica Sileo, Federico Alghisi, Chiara Premuda, Andrea Gramegna, Francesco Blasi, Stefano Costa, Maria Cristina Lucanto, Vincenzina Lucidi, Arianna Bisogno und 2 weitere

Diabetes Care · 20.11.2026

DOI: 10.2337/dc26-1988 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diabetes Care, online erschienen am 20.11.2026. Verfasst von Andrea Foppiani und 13 weiteren Autor:innen. Gefördert von: Fondazione per la Ricerca sulla Fibrosi Cistica.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE To determine whether the 30-min C-peptide response during an oral glucose tolerance test (OGTT) is associated with incident cystic fibrosis-related diabetes (CFRD) in people with CF (pwCF) and normal glucose tolerance (NGT), for whom no risk-stratification tool exists. RESEARCH DESIGN AND METHODS In this multicenter retrospective cohort study, 309 pwCF (age ≥8 years) from three Italian CF referral centers were followed for a median of 8.8 years (interquartile range [IQR] 7.4–17.3). Baseline OGTT-derived markers of β-cell function and insulin sensitivity were compared using time-varying Cox models adjusted for age, sex, BMI, forced expiratory volume in 1 s (% predicted), and modulator exposure, in the full cohort and a baseline NGT subgroup (n = 222), with bootstrap validation; an exploratory threshold was derived by grid search. RESULTS CFRD developed in 70 of 309 pwCF (22.7%). OGTT categories and 120-min glucose showed the strongest discrimination. Among NGT pwCF, β-cell glucose sensitivity, 30-min insulin, 30-min C-peptide, and 60-min glucose were associated with CFRD; HOMA-insulin resistance and the Oral Glucose Insulin Sensitivity-120 index were not. Each IQR increase in 30-min C-peptide was associated with lower CFRD hazard (hazard ratio [HR] 0.52, 95% CI 0.30–0.92), robustly across specifications, although shrinkage suggested a smaller effect (HR 0.64–0.76). An exploratory 4.65 ng/mL (1.54 nmol/L) cutoff separated the two risk groups but was unstable under bootstrap resampling. Modulator exposure was associated with lower CFRD hazard (HR 0.27, 95% CI 0.08–0.89). CONCLUSIONS Lower 30-min C-peptide is independently associated with incident CFRD in pwCF with NGT. Any risk threshold is exploratory and requires external validation before clinical use.

Förderung

  • Fondazione per la Ricerca sulla Fibrosi Cistica

Zitieren

APA

Foppiani, A., Ciciriello, F., Marelli, B., Sileo, F., Alghisi, F., Premuda, C., Gramegna, A., Blasi, F., Costa, S., Lucanto, M. C., Lucidi, V., Bisogno, A., Colombo, C., & Battezzati, A. (2026). Early-Phase C-Peptide Response as a Candidate Predictor of Cystic Fibrosis-Related Diabetes in People With Normal Glucose Tolerance: A Multicenter Retrospective Survival Analysis. Diabetes Care. https://doi.org/10.2337/dc26-1988

Vancouver

Foppiani A, Ciciriello F, Marelli B, Sileo F, Alghisi F, Premuda C, et al. Early-Phase C-Peptide Response as a Candidate Predictor of Cystic Fibrosis-Related Diabetes in People With Normal Glucose Tolerance: A Multicenter Retrospective Survival Analysis. Diabetes Care. 2026. doi:10.2337/dc26-1988

BibTeX
@article{Foppiani2026,
  author = {Foppiani, Andrea and Ciciriello, Fabiana and Marelli, Beatrice and Sileo, Federica and Alghisi, Federico and Premuda, Chiara and Gramegna, Andrea and Blasi, Francesco and Costa, Stefano and Lucanto, Maria Cristina and Lucidi, Vincenzina and Bisogno, Arianna and Colombo, Carla and Battezzati, Alberto},
  title = {Early-Phase C-Peptide Response as a Candidate Predictor of Cystic Fibrosis-Related Diabetes in People With Normal Glucose Tolerance: A Multicenter Retrospective Survival Analysis},
  journal = {Diabetes Care},
  year = {2026},
  doi = {10.2337/dc26-1988}
}
Kostenlos starten →